New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 22, 2013
09:38 EDTSNYEMA rejects Genzyme re-examination request for Kynamro
Genzyme, a Sanofi company, requested a re-examination of the Committee for Medicinal Products for Human Use previous adoption of a negative opinion recommending the refusal of the marketing authorization for the medicinal product Kynamro, intended for the treatment of patients with certain forms of familial hypercholesterolaemia. After considering the grounds for this request, the CHMP re-examined the initial opinion, and confirmed the refusal of the marketing authorization on March 21, the EMA announced earlier.
News For SNY From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
December 9, 2014
11:19 EDTSNYSanofi reportedly ready to make acquisitions in animal medicine, Bloomberg says
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use